{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:49:43Z","timestamp":1770979783996,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ajog.2012.05.003","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T15:44:52Z","timestamp":1336491892000},"page":"140.e1-140.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Examining the correlation between placental and serum placenta growth factor in preeclampsia"],"prefix":"10.1016","volume":"207","author":[{"given":"Samantha","family":"Weed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie A.","family":"Bastek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Anton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal A.","family":"Elovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu K.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2012.05.003_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2012.05.003_bib2","first-page":"159","article-title":"Diagnosis and management of preeclampsia and eclampsia","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib3","first-page":"1","article-title":"Births: final data for 2007","volume":"58","author":"Martin","year":"2010","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2012.05.003_bib4","first-page":"533","article-title":"Pregnancy-related mortality from preeclampsia and eclampsia","volume":"97","author":"MacKay","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib5","first-page":"1","article-title":"Pregnancy-related mortality surveillance- United States, 1991-1999","volume":"52","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.ajog.2012.05.003_bib6","first-page":"24","article-title":"Pregnancy outcomes in healthy nulliparas who developed hypertension","volume":"95","author":"Hauth","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ogc.2010.02.013","article-title":"Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia","volume":"37","author":"Silasi","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2012.05.003_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/jc.2007-1550","article-title":"Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies","volume":"93","author":"Gu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2012.05.003_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","article-title":"Placental origins of preeclampsia: challenging the current hypothesis","volume":"51","author":"Huppertz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2012.05.003_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF02828055","article-title":"Analysis of placental growth factor in placentas of normal pregnant women and women with hypertensive disorders of pregnancy","volume":"26","author":"Shen","year":"2006","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.ajog.2012.05.003_bib11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3109\/14767051003677988","article-title":"The use of angiogenic factors in discriminating preeclampsia: are they ready for prime time?","volume":"23","author":"Srinivas","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2012.05.003_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10641950701825937","article-title":"Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension","volume":"27","author":"Teixeira","year":"2008","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2012.05.003_bib13","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstrom","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajog.2005.12.049","article-title":"Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia","volume":"195","author":"Robinson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib15","doi-asserted-by":"crossref","first-page":"152.e1","DOI":"10.1016\/j.ajog.2010.08.049","article-title":"Circulating angiogenic and antiangiogenic factors in women with eclampsia","volume":"204","author":"Vaisbuch","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib16","first-page":"77","article-title":"Circulating angiogenic factors in pregnancies complicated by pre-eclampsia","volume":"23","author":"Varughese","year":"2010","journal-title":"Natl Med J India"},{"key":"10.1016\/j.ajog.2012.05.003_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/hr.2010.31","article-title":"Circulating angiogenic factors and their association with birth outcomes in preeclampsia","volume":"33","author":"Kulkarni","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2012.05.003_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/08977190903184670","article-title":"Fetal and maternal angiogenic\/anti-angiogenic factors in normal and preeclamptic pregnancy","volume":"27","author":"Catarino","year":"2009","journal-title":"Growth Factors"},{"key":"10.1016\/j.ajog.2012.05.003_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/1933719109336622","article-title":"Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women","volume":"16","author":"Purwosunu","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2012.05.003_bib20","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1067\/mob.2000.108022","article-title":"Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia","volume":"183","author":"Livingston","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2012.05.003_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2012.05.003_bib23","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2012.05.003_bib24","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2010.02690.x","article-title":"First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia","volume":"117","author":"Wortelboer","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2012.05.003_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/uog.8800","article-title":"Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia","volume":"37","author":"Yu","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib26","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.ajog.2010.06.014","article-title":"Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women","volume":"203","author":"Audibert","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pd.2525","article-title":"First-trimester placental growth factor as a marker for hypertensive disorders and SGA","volume":"30","author":"Cowans","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2012.05.003_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00016340903289892","article-title":"Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia","volume":"89","author":"Shokry","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2012.05.003_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2012.05.003_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.109.895458","article-title":"Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension","volume":"122","author":"Noori","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2012.05.003_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1034\/j.1600-0412.2003.00206.x","article-title":"Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels","volume":"82","author":"Madazli","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2012.05.003_bib32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/hr.2010.92","article-title":"Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia","volume":"33","author":"Molvarec","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2012.05.003_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.2009.02453.x","article-title":"Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia","volume":"117","author":"Masuyama","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2012.05.003_bib34","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","article-title":"A vascular endothelium growth factor antagonist is produced by the human placenta and released into the maternal circulation","volume":"59","author":"Clark","year":"1998","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2012.05.003_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A United States national reference for fetal growth","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","article-title":"Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial","volume":"171","author":"Sibai","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib37","doi-asserted-by":"crossref","first-page":"514.e1","DOI":"10.1016\/j.ajog.2007.02.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications","volume":"196","author":"Sibai","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.05.003_bib38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3109\/14767051003678242","article-title":"Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women","volume":"23","author":"Law","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2012.05.003_bib39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/eje.0.1470785","article-title":"Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term","volume":"147","author":"Bersinger","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ajog.2012.05.003_bib40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.metabol.2011.03.021","article-title":"Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study","volume":"60","author":"Dalamaga","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.ajog.2012.05.003_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0029-1241735","article-title":"N-terminal pro-brain natriuretic peptide as a biomarker for hypertensive disorders of pregnancy","volume":"27","author":"Moghbeli","year":"2010","journal-title":"Am J Perinatol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812004863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812004863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:44:54Z","timestamp":1757587494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937812004863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0002937812004863"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2012.05.003","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the correlation between placental and serum placenta growth factor in preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2012.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}